
Arthrosamid Injection for Patellofemoral Osteoarthritis Relief
Patellofemoral osteoarthritis, affecting the kneecap, causes pain and mobility challenges during activities like climbing stairs and cycling. Arthrosamid, a non-surgical injectable hydrogel, cushions the patellofemoral joint, reducing pain and improving function by mimicking natural joint fluid. Supported by emerging research, this innovative treatment offers a promising option for patients seeking to manage kneecap osteoarthritis symptoms. Expert clinicians, including Professor Paul Lee and MSK Doctors, provide tailored assessments to identify suitable candidates for Arthrosamid, ensuring personalized care. While further studies are needed to define optimal patient profiles, Arthrosamid represents a minimally invasive alternative to traditional treatments, enhancing quality of life for those affected by patellofemoral osteoarthritis.








